In our experiments, we confirmed the role of a miR-146b-5p/SMARCA5/TGF-β axis in malignant F-GSC/MSCs in the glioma microenvironment, which may be a potential therapeutic target for treatment of glioma in the future. Here, SMARCA5 is linked to central nervous system cancer.